The Patent Finder

Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease

Halozyme Hypercon, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2020/050508, filed Sep 11, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,459,376Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease
In force
 · Low confidence
Halozyme Hypercon, Inc.In force
Low confidence
US 12,600,763Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease
In force
 · Medium confidence
Halozyme Hypercon, Inc.In force
Medium confidence
Application 18/906,489Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease
Pending
Not granted
Halozyme Hypercon, Inc.PendingNot granted
Application 19/549,897Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease
Pending
Not granted
Halozyme Hypercon, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Halozyme Hypercon, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited